HYPD
Hyperion DeFi, Inc.
There isn't enough reported data to score HYPD yet.
NVO
Novo Nordisk A/S
NVO's fundamentals are mixed: it turned 15% of its revenue into free cash flow, but its operating margin fell 3 points to 43%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
HYPD Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Unavailable | |
| Unavailable |
HYPD's revenue and profitability are currently strong. There isn't enough data to rate its cash flow and balance sheet.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
HYPD PE Valuation
HYPD has no meaningful PE right now: it lost money over the past year.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
HYPD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect HYPD's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
HYPD Earnings Per Share
HYPD and NVO do not have enough comparable growth data to identify a winner.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO's earnings per share have climbed steadily: $3.89 over the past year, up 4.9% from the year before, and higher year over year every quarter since late 2020.
HYPD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $244.3K | +1559% |
| Q4 2025 | $496.2K | +1666% |
| Q3 2025 | $302.5K | +18516% |
| Q1 2025 | $14.7K | +195% |
| Q4 2024 | $28.1K | +985% |
| Q3 2024 | $1.6K | +36% |
HYPD's revenue has grown year over year for four quarters in a row: $357,693 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 8669% | N/A |
| Q1 2026 | 3575% | +24164 points |
| Q4 2025 | -8013% | +61225 points |
| Q3 2025 | 1464% | +452659 points |
| Q1 2025 | -20589% | +185035 points |
| Q4 2024 | -69238% | +219157 points |
| Q3 2024 | -451196% | +93060 points |
| Q2 2024 | -51661% | N/A |
HYPD has the edge over NVO on profitability, with a higher operating margin.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO's revenue is growing: $11.7B last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO's operating margin was 34% last quarter, down 9 points from the same quarter a year ago, near the bottom of its range since 2019.
HYPD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$6.1M | +$356.5K |
| Q3 2024 | -$5.9M | +$475.6K |
| Q2 2024 | -$8.2M | -$2.3M |
| Q1 2024 | -$10M | -$2.1M |
| Q4 2023 | -$6.5M | -$1M |
| Q3 2023 | -$6.4M | +$624K |
| Q2 2023 | -$5.9M | -$1.1M |
| Q1 2023 | -$7.9M | +$479.4K |
HYPD has the stronger cash trend. Its trailing FCF is down 12% versus its history, compared with NVO at down 14%.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO still generates free cash flow, though less than at its 2026 peak: $7.3B over the past year.
HYPD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +61% | +1.3M shares |
| 1 year | +430% | +2.9M shares |
| 3 years | +737% | +3.1M shares |
| 5 years | +1320% | +3.3M shares |
HYPD has 4M diluted shares, up 430% from a year ago.
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over HYPD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
HYPD Net Leverage
HYPD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
HYPD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.4 | Neutral |
| Stochastic | 25.1 | Neutral |
HYPD's weekly RSI is 43 (neutral) and its Stochastic is 25 (neutral).
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
HYPD PE vs Healthcare Sector
HYPD has no meaningful PE right now: it lost money over the past year.
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO is trading at 10x earnings, a 60% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
HYPD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.16 | 14% below |
| 20 week MA | $3.09 | 12% below |
| 50 week MA | $3.34 | 19% below |
| 100 week MA | $4.42 | 38% below |
| 200 week MA | $68.7 | 96% below |
HYPD is in a downtrend: it's below all five of its weekly moving averages, and 96% below its 200-week average.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has the edge over HYPD on trend strength, trading above more of its moving averages.
HYPD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $305.6 | $455.2 | +49% |
| 2021 | $455.2 | $329.6 | -28% |
| 2022 | $329.6 | $128.8 | -61% |
| 2023 | $128.8 | $166.4 | +29% |
| 2024 | $166.4 | $7.52 | -95% |
| 2025 | $7.52 | $3.84 | -49% |
| 2026 YTD | $3.84 | $2.72 | -29% |
HYPD has finished lower in four of the last six years. It's down 29% so far in 2026.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has the edge over HYPD on returns for 2026, with the stronger performance.